Assembly Biosciences, Inc. Marketable Securities, Unrealized Gain (Loss)
Assembly Biosciences, Inc. (ASMB) reported Marketable Securities, Unrealized Gain (Loss) of -$112.00 thousand for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2021-02-25
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-12-31 was -$112.00K, a 2900.00% decline year-over-year.
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-09-30 was -$262.00K.
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-06-30 was $190.00K, a 265.38% increase year-over-year.
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2020-03-31 was $115.00K, a 6.48% increase year-over-year.
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for fiscal 2015 was -$821.59K.
- Assembly Biosciences, Inc. marketable securities, unrealized gain (loss) for fiscal 2014 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$112.00K 10-K · filed 2021-02-25 | -$374.00K derived: sum of 2 quarters · filed 2021-02-25 | -$184.00K derived: sum of 3 quarters · filed 2021-02-25 | -$69.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-09-30 | -$262.00K 10-K · filed 2021-02-25 | -$72.00K derived: sum of 2 quarters · filed 2021-02-25 | $43.00K derived: sum of 3 quarters · filed 2021-02-25 | $47.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-06-30 | $190.00K 10-K · filed 2021-02-25 | $305.00K derived: sum of 2 quarters · filed 2021-02-25 | $309.00K derived: sum of 3 quarters · filed 2021-02-25 | $291.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-03-31 | $115.00K 10-K · filed 2021-02-25 | $119.00K derived: sum of 2 quarters · filed 2021-02-25 | $101.00K derived: sum of 3 quarters · filed 2021-02-25 | $153.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | $4.00K 10-K · filed 2021-02-25 | -$14.00K derived: sum of 2 quarters · filed 2021-02-25 | $38.00K derived: sum of 3 quarters · filed 2021-02-25 | $146.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-09-30 | -$18.00K 10-K · filed 2021-02-25 | $34.00K derived: sum of 2 quarters · filed 2021-02-25 | $142.00K derived: sum of 3 quarters · filed 2021-02-25 | $373.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $52.00K 10-K · filed 2021-02-25 | $160.00K derived: sum of 2 quarters · filed 2021-02-25 | $391.00K derived: sum of 3 quarters · filed 2021-02-25 | $309.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $108.00K 10-K · filed 2021-02-25 | $339.00K derived: sum of 2 quarters · filed 2021-02-25 | $257.00K derived: sum of 3 quarters · filed 2021-02-25 | $130.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $231.00K 10-K · filed 2020-03-04 | $149.00K derived: sum of 2 quarters · filed 2020-03-04 | $22.00K derived: sum of 3 quarters · filed 2020-03-04 | -$1.00K derived: sum of 4 quarters · filed 2020-03-04 |
| 2018-09-30 | -$82.00K 10-K · filed 2020-03-04 | -$209.00K derived: sum of 2 quarters · filed 2020-03-04 | -$232.00K derived: sum of 3 quarters · filed 2020-03-04 | -$270.00K derived: sum of 4 quarters · filed 2020-03-04 |
| 2018-06-30 | -$127.00K 10-K · filed 2020-03-04 | -$150.00K derived: sum of 2 quarters · filed 2020-03-04 | -$188.00K derived: sum of 3 quarters · filed 2020-03-04 | -$287.00K derived: sum of 4 quarters · filed 2020-03-04 |
| 2018-03-31 | -$23.00K 10-K · filed 2020-03-04 | -$61.00K derived: sum of 2 quarters · filed 2020-03-04 | -$160.00K derived: sum of 3 quarters · filed 2020-03-04 | -$501.00K derived: sum of 4 quarters · filed 2020-03-04 |
| 2017-12-31 | -$38.00K 10-K · filed 2019-02-28 | -$137.00K derived: sum of 2 quarters · filed 2019-02-28 | -$478.00K derived: sum of 3 quarters · filed 2019-02-28 | -$615.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-09-30 | -$99.00K 10-K · filed 2019-02-28 | -$440.00K derived: sum of 2 quarters · filed 2019-02-28 | -$577.00K derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-06-30 | -$341.00K 10-K · filed 2019-02-28 | -$478.00K derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2017-03-31 | -$137.00K 10-K · filed 2019-02-28 | |||
| 2016-03-31 | $72.09K 10-Q · filed 2016-05-10 | -$361.62K derived: sum of 2 quarters · filed 2016-05-10 | -$615.28K derived: sum of 3 quarters · filed 2016-05-10 | -$749.50K derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | -$433.71K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$687.37K derived: sum of 2 quarters · filed 2016-03-11 | -$821.59K derived: sum of 3 quarters · filed 2016-03-11 | -$821.59K 10-K · filed 2016-03-11 |
| 2015-09-30 | -$253.66K 10-Q · filed 2015-11-09 | -$387.88K derived: sum of 2 quarters · filed 2015-11-09 | -$387.88K 10-Q · filed 2015-11-09 | -$387.88K derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-06-30 | -$134.22K 10-Q · filed 2015-08-13 | -$134.22K 10-Q · filed 2015-08-13 | -$134.22K derived: sum of 3 quarters · filed 2016-05-10 | -$134.22K derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | $0.00 derived: sum of 2 quarters · filed 2016-05-10 | $0.00 derived: sum of 3 quarters · filed 2016-05-10 | $0.00 derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $0.00 derived: sum of 2 quarters · filed 2016-03-11 | $0.00 derived: sum of 3 quarters · filed 2016-03-11 | $0.00 10-K · filed 2016-03-11 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |